• OpenAccess
  • Trend of Invasive Streptococcus agalactiae at Tertiary Care Hospital in Japan  [CLMCR 2016]
  • DOI: 10.4236/jbm.2016.43003   PP.15 - 20
  • Author(s)
  • Masaaki Minami, Hideki Nishiyama, Shinobu Ikegami, Takuya Hattori, Makoto Kawashima, Michio Ohta
  • Streptococcus agalactiae causes various severe infectious diseases such as sepsis, meningitis, and streptococcal toxic shock-like syndrome. Though Streptococcus agalactiae infection has been increasing recently, the comprehensive characteristic investigation of invasive Streptococcus agalactiae isolated in tertiary care hospitals has not been nearly performed in Japan. In this study, we investigated the clinical characteristics and antimicrobial susceptible patterns of 88 Streptococcus agalactiae isolated at two tertiary care hospitals during 2009-2015 in Japan. There was no significant differences between genders in our study. Two-third Streptococcus agalactiae were isolated from over age 60. Total mortality rate was 19% and invasive Streptococcus agalactiae-associated death cases have occurred every year after 2011. All Streptococcus agalactiae were completely susceptible toampicillin. Total non-susceptible rates of erythromycin, minocycline, levofloxacin and trimethoprim-sulfamethoxazole in this study were approximately 30%, 44%, 37%, and 7%, respectively. Our results suggest the need for continuous antimicrobial susceptibility survey of Streptococcus agalactiae.

  • Streptococcus agalactiae, Susceptibility, Antimicrobial Resistance, Epidemiology
  • References
  • [1]
    Dhanoa, A., Karunakaran, R. and Puthucheary, S.D. (2010) Serotype Distribution and Antibiotic Susceptibility of Group B Streptococci in Pregnant Women. Epidemiol Infect, 138, 979-981.
    Skoff, T.H., Farley, M.M., Petit, S., Craig, A.S., Schaffner, W., Gershman, K., et al. (2009) Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990-2007. Clin Infect Dis., 49, 85-92.
    Al Akhrass, F., Abdallah, L., Berger, S., Hanna, R., Reynolds, N., Thompson, S., et al. (2013) Streptococcus agalactiae Toxic Shock-Like Syndrome: Two Case Reports and Review of the Literature. Medicine (Baltimore), 92, 10-14.
    Colford Jr., J.M., Mohle-Boetani, J. and Vosti, K.L. (1995) Group B Streptococcal Bacteremia in Adults. Five Years’ Experience and a Review of the Literature. Medicine (Bal-timore), 74,176-190.
    Ikebe, T., Chiba, K., Shima, T., Masuda, C., Okuno, R., Ohya, H., et al., Working Group for Beta-Hemolytic Streptococci in Japan (2015) Evaluation of Streptococcal Toxic Shock-Like Syndrome Caused by Group B Streptococcus in Adults in Japan between 2009 and 2013. J Infect Chemother, 21, 207-211.
    Chu, Y.W., Tse, C., Tsang, G.K., So, D.K., Fung, J.T. and Lo, J.Y. (2007) Invasive Group B Streptococcus Isolates Showing Reduced Susceptibility to Penicillin in Hong Kong. J Antimicrob Chemother, 60, 1407-1409.
    Wang, Y.H., Chen, C.L., Hou, J.N., Wang, Y.R., Lin, T.Y., Wang, M.H., et al. (2015) Serotype Distribution and Resistance Genes Associated with Macrolide and Fluoroquinolone Resistance in Streptococcus agalactiae Isolates from a Hospital in Southern Taiwan. Biomed Journal, 38, 215-220.
    Phares, C.R., Lynfield, R., Farley, M.M., Mohle-Boetani, J., Harrison, L.H., Petit, S., et al., Active Bacterial Core Surveillance/Emerging Infections Program Network (2008) Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005. JAMA, 299, 2056-2065.
    Banno, H., Kimura, K., Tanaka, Y., Kitanaka, H., Jin, W., Wachino, J., et al. (2014) Characterization of Multidrug- Resistant Group B Streptococci with Reduced Penicillin Susceptibility Forming Small Non-Beta-Hemolytic Colonies on Sheep Blood Agar Plates. J Clin Microbiol., 52, 2169-2171.
    Hashikawa, S., Iinuma, Y., Furushita, M., Ohkura, T., Nada, T., Torii, K., et al. (2004) Characterization of Group C and G Streptococcal Strains That Cause Streptococcal Toxic Shock Syndrome. J Clin Microbiol., 42, 186-192.
    Clinical and Laboratory Standards Institute (CLSI) (2014) Performance Standards for Antimicrobial Susceptibility Testing: 24st Informational Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.
    Kimura, K., Nishiyama, Y., Shimizu, S., Wachino, J., Matsui, M., Suzuki, S., et al. (2013) Screening for Group B Streptococci with Reduced Penicillin Susceptibility in Clinical Isolates Obtained between 1977 and 2005. Jpn J Infect Dis., 66, 222-225.
    The Working Group on Severe Streptococcal Infections (1993) Defining the Group A Streptococcal Toxic Shock Syndrome. Rationale and Consensus Definition. JAMA, 269, 390-391.
    Ueno, H., Yamamoto, Y., Yamamichi, A., Kikuchi, K., Kobori, S. and Miyazaki, M. (2012) Characterization of Group B Streptococcus Isolated from Women in Saitama City, Japan. Jpn J Infect Dis., 65, 516-521.
    Minami, M., Sakakibara, R., Imura, T., Morita, H., Kanemaki, N. and Ohta, M. (2014) Prevalence and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae at General Hospital in the Central Region of Japan from December 2013 to February 2014. J. Biosciences. Medicine, 2, 12-17.
    Davis, R. and Bryson, H.M. (1994) Levofloxacin. A Review of Its Antibacterial Activity, Pharmacokinetics and Therapeutic Efficacy. Drugs, 47, 677-700.

Engineering Information Institute is the member of/source content provider to